News & Updates

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

23 Sep 2023 by

The FDA-approved intrauterine vacuum-induced haemorrhage-control device rapidly controls bleeding in both vaginal and caesarean births, with a safety profile consistent with that observed in the registrational trial, as shown in a postmarket registry medical record review study.

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

23 Sep 2023

NSAIDs up VTE risk in women using hormonal contraception

20 Sep 2023 by

Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) appears to increase the risk of venous thromboembolism (VTE) in women using hormonal contraception, reveals a study.

NSAIDs up VTE risk in women using hormonal contraception

20 Sep 2023

Cognitive behavioural, light dark therapy help fight postpartum insomnia

18 Sep 2023 by

New mothers who are struggling to fall or stay asleep may find relief from therapist-assisted cognitive behavioural therapy (CBT) and light dark therapy (LDT), which have been shown to be safe and effective at reducing postpartum insomnia symptoms.

Cognitive behavioural, light dark therapy help fight postpartum insomnia

18 Sep 2023

Original New Drug Application Approvals by US FDA (01-15 September 2023)

15 Sep 2023

New drug applications approved by US FDA as of 01-15 September 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 September 2023)

15 Sep 2023

Postnatal SSRI treatment helps with postnatal depression–associated problems

06 Sep 2023

Treating postnatal depression with selective serotonin reuptake inhibitors (SSRIs) may be beneficial for both mothers and their children in the long term, with a recent study showing that SSRIs can reduce the risk of several negative outcomes, such as maternal depression and child behavioural problems, according to a study.

Postnatal SSRI treatment helps with postnatal depression–associated problems

06 Sep 2023

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

05 Sep 2023

Combination treatment with pembrolizumab and lenvatinib appears to be a better option for patients with recurrent endometrial cancer (REC) or advanced endometrial cancer (AEC) with a platinum-free interval (PFI) of <6 months, suggests a recent study.

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

05 Sep 2023

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Women who conceive following infertility treatment appear to have a higher likelihood of stroke-related hospitalization within 12 months of delivery as compared with those who spontaneously conceive, according to a study.

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Music therapy aids perimenopausal women

04 Sep 2023

Music therapy appears to benefit perimenopausal women by easing their psychological and emotional symptoms, according to a study.

Music therapy aids perimenopausal women

04 Sep 2023

US FDA greenlights first pill for postpartum depression

31 Aug 2023 by

The US Food and Drug Administration (FDA) has approved the first oral medication for postpartum depression in adults, giving clinicians a new therapeutic option for this debilitating condition.

US FDA greenlights first pill for postpartum depression

31 Aug 2023

General anaesthesia and oxytocin significantly associated with PPH in twin pregnancies

31 Aug 2023 by

A retrospective cohort study of twin pregnancies in Hong Kong has identified general anaesthesia (GA) and use of oxytocin as significant risk factors for all postpartum haemorrhage (PPH; ≥500 mL). The study also shows that GA, in vitro fertilization (IVF), antepartum haemorrhage, placental abruption, and placenta praevia (PP) are significantly associated with major PPH (>1,000 mL), while IVF, PP, and obesity are significant risk factors for severe PPH (>1,500 mL).

General anaesthesia and oxytocin significantly associated with PPH in twin pregnancies

31 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

NSAIDs up VTE risk in women using hormonal contraception

NSAIDs up VTE risk in women using hormonal contraception

Cognitive behavioural, light dark therapy help fight postpartum insomnia

Cognitive behavioural, light dark therapy help fight postpartum insomnia

Original New Drug Application Approvals by US FDA (01-15 September 2023)

Original New Drug Application Approvals by US FDA (01-15 September 2023)

Postnatal SSRI treatment helps with postnatal depression–associated problems

Postnatal SSRI treatment helps with postnatal depression–associated problems

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

Infertility treatment carries increased risk of stroke hospitalization

Infertility treatment carries increased risk of stroke hospitalization

Music therapy aids perimenopausal women

Music therapy aids perimenopausal women

US FDA greenlights first pill for postpartum depression

US FDA greenlights first pill for postpartum depression

General anaesthesia and oxytocin significantly associated with PPH in twin pregnancies

General anaesthesia and oxytocin significantly associated with PPH in twin pregnancies